Safety and efficacy of prophylaxis and on-demand treatment with BAY 94-9027: results of a phase 2/3 multicentre, partially randomized, open-label trial

被引：0
|
作者：
Reding, Mark [1 ]
Powell, Jerry [2 ]
Santagostino, Elena [3 ]
Ng, Heng Joo [4 ]
Lederman, Mel [5 ]
Wang, Maria [5 ]
Walsch, Rene [6 ]
Sax, Mirjam [7 ]
Michaels, Lisa A. [5 ]
机构：
[1] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA
[2] Univ Calif Davis, Sacramento, CA 95817 USA
[3] Maggiore Hosp Policlin, IRCCS Ca Granda Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[4] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[5] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[6] Bayer Vital GmbH, Leverkusen, Germany
[7] Bayer Pharma AG, Berlin, Germany
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
    Himanshu P. Upadhyaya
    Jenny Y. Chien
    Amanda J. Long
    Martin S. Bohm
    Nicole L. Kallewaard
    Lisa F. Macpherson
    Dipak R. Patel
    Matthew M. Hufford
    Constance J. Krull
    Jocelyn Y. Ang
    Peter Chen
    William J. Muller
    Jeffrey A. Potts
    Timothy Quinn
    Mark Williams
    Infectious Diseases and Therapy, 2023, 12 : 1861 - 1873
  • [42] Efficacy of ready-to-use therapeutic food in malnourished children with cancer: Results of a randomized, open-label phase 3 trial
    Prasad, Maya
    Tandon, Sneha
    Gala, Rajul
    Kannan, Sadhna
    Chinnaswamy, Girish
    Narula, Gaurav
    Vora, Tushar
    Banavali, Shripad
    Mehta, Shaesta
    Paradkar, Amey
    Goswami, Savita
    Ghadge, Meera
    Jagiasi, Deepak
    Sharma, Sujata
    Fernandes, Lavina
    Manglani, Mamta
    Jadhav, Alka
    Barr, Ronald
    Ladas, Elena
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [43] Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial
    Gnessi, Lucio
    Bacarea, Vladimir
    Marusteri, Marius
    Pique, Nuria
    BMC GASTROENTEROLOGY, 2015, 15
  • [44] Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial
    Lucio Gnessi
    Vladimir Bacarea
    Marius Marusteri
    Núria Piqué
    BMC Gastroenterology, 15
  • [45] The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China
    Xiao, Ying Lian
    Nie, Yu Qiang
    Hou, Xiao Hua
    Xie, Peng Yan
    Fang, Jing Yuan
    Yuan, Yao Zong
    Zhou, Li Ya
    Zhao, Nai Qing
    Chen, Min Hu
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (09) : 463 - 468
  • [46] Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial
    Kumesu, Victor Kande Betu
    Kalonji, Wilfried Mutombo
    Bardonneau, Clelia
    Mordt, Olaf Valverde
    Tete, Digas Ngolo
    Blesson, Severine
    Simon, Francois
    Delhomme, Sophie
    Bernhard, Sonja
    Ngima, Pathou Nganzobo
    Mbembo, Helene Mahenzi
    Lubaki, Jean-Pierre Fina
    Vuvu, Steven Lumeya
    Mindele, Willy Kuziena
    Kyhi, Medard Ilunga Wa
    Mokenge, Guylain Mandula
    Badibabi, Lewis Kaninda
    Bonama, Augustin Kasongo
    Lukula, Papy Kavunga
    Lumbala, Crispin
    Scherrer, Bruno
    Strub-Wourgaft, Nathalie
    Tarral, Antoine
    LANCET GLOBAL HEALTH, 2022, 10 (11): : E1665 - E1674
  • [47] Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial
    Abdellatif, Abdul
    Zhao, Lin
    Chamberlain, Jason
    Cherny, Katya
    Xin, Yan
    Marder, Brad A.
    Scandling, John D.
    Saag, Kenneth
    CLINICAL TRANSPLANTATION, 2023, 37 (09)
  • [48] Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study
    Harland, Robert C.
    Klintmalm, Goran
    Jensik, Stephen
    Yang, Harold
    Bromberg, Jonathan
    Holman, John
    Kumar, Mysore S. A.
    Santos, Vicki
    Larson, Tami J.
    Wang, Xuegong
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (01) : 159 - 171
  • [49] Efficacy and Safety of Bleselumab in Kidney Transplant Recipients: A Phase 2, Randomized, Open-Label Study.
    Harland, R.
    Klintmalm, G.
    Jensik, S.
    Yang, H.
    Bromberg, J.
    Holman, J.
    Kumar, M. Anil
    Santos, V.
    Larson, T.
    Wang, X.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 447 - 448
  • [50] Efficacy of adalimumab in the treatment of preiradiographic axial spondyloarthritis: Results of a 20-week, randomized controlled trial with an open-label extension phase
    Haibel, H.
    Rudwaleit, M.
    Amtenbrink, A.
    Heldmann, F.
    Listing, J.
    Wong, R.
    Kupper, H.
    Braun, J.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 64 - 64
12345